Navigation Links
IGC scientist awarded prestigious European Research Council Starting grant
Date:8/24/2009

Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.

Rui Costa explains the aims of his research programme, 'We are daily, constantly having to make decisions and select appropriate actions to obtain specific goals. Actions may be selected on the basis of their consequences - for example, driving work with the aim of getting home. This type of goal-directed behaviour demands constant control and monitoring of those goals and consequences - an effortful endeavour. However, if we repeat the same action often enough, it may become automatic, that is, a habit, and the effort it requires may be reduced.'

'Habitual responses do not need constant evaluation of the consequences, and are often at play even when we wish to do something different - for example, we may wish to drive home from work, but end up somewhere else. There is increasing evidence that the neural circuits underlying goal-directed and habit-based decisions are different. Our aim is to establish the differences between these neural processes, both at the cellular and molecular level. To achieve this, we will be using cutting-edge molecular biology and electrophysiology (recording electrical activity in the brain) techniques. If we could unravel the processes whereby goal-directed and habit behaviour are determined, we would be closer to understanding not only decision-making processes, but also, obsessive behaviour disorders', adds Rui.

Indeed, this research may provide insight into decision-making on a day-to-day level, for example, when we decide to make a certain type of investment, or a certain purchase, why we opt for a different behaviour or, on the contrary, stick to a routine. On the other hand, findings in this area may shed some light on the mechanisms underlying a range of psychiatric disorders, namely those involving compulsive or addictive behaviours.

Now in it's second edition, the ERC Starting Grants aim to support early career independent researchers (with three to eight years' research experience since completion of their PhD), with a promising scientific track record and proposing to carry out an ambitious and ground-breaking research proposal. The main selection criteria for these, and other, ERC awards is scientific excellence, and all areas of research are covered in the funding scheme.

Of the 2503 applications received in 2009, from 34 countries (EU member sates, Switzerland, Norway, Israel and Turkey), 42 came form scientists working in Portugal, across Life Sciences, Physical Sciences and Engineering and Social Sciences and Humanities. To date, 219 grants are confirmed, three of which for scientists working in Portugal, of which Rui Costa is one of the awardees.

Antonio Coutinho, director of the IGC, and Leonor Beleza, President of the Champalimaud Foundation, agree that this prestigious grant acknowledges the leading position of the IGC and the Champalimaud Neuroscience Porgramme, both within the scientific community, and with international funding agencies.


'/>"/>

Contact: Silvia Castro
sacastro@igc.gulbenkian.pt
351-214-464-537
Instituto Gulbenkian de Ciencia
Source:Eurekalert  

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IGC scientist awarded prestigious European Research Council Starting grant
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology: